Compare BLLN & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | CAKE |
|---|---|---|
| Founded | 2016 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.5B |
| IPO Year | 2025 | 1996 |
| Metric | BLLN | CAKE |
|---|---|---|
| Price | $109.83 | $114.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 19 |
| Target Price | ★ $129.00 | $106.27 |
| AVG Volume (30 Days) | 456.0K | ★ 1.5M |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.06% |
| EPS Growth | ★ 103.40 | N/A |
| EPS | 0.48 | ★ 2.43 |
| Revenue | $305,112,000.00 | ★ $3,751,806,000.00 |
| Revenue This Year | $49.33 | $9.02 |
| Revenue Next Year | $26.38 | $8.40 |
| P/E Ratio | $237.01 | ★ $46.14 |
| Revenue Growth | ★ 99.97 | 4.75 |
| 52 Week Low | $61.96 | $43.07 |
| 52 Week High | $150.44 | $118.63 |
| Indicator | BLLN | CAKE |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 58.24 |
| Support Level | $89.26 | $102.42 |
| Resistance Level | $127.72 | $115.97 |
| Average True Range (ATR) | 5.53 | 4.82 |
| MACD | 1.15 | -0.21 |
| Stochastic Oscillator | 60.41 | 81.91 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.